Galmed Pharmaceuticals Ltd. (GLMD)
4.02
-0.28
(-6.62%)
USD |
NASDAQ |
Aug 24, 16:00
4.02
0.00 (0.00%)
After-Hours: 20:00
Galmed Pharmaceuticals Price : 4.02 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 4.54 | 4.54 | 4.12 | 4.305 | 22210.00 |
| Aug 20, 2026 | 4.56 | 4.80 | 4.22 | 4.56 | 107782.0 |
| Aug 19, 2026 | 5.38 | 5.450 | 4.10 | 4.77 | 231141.0 |
| Aug 18, 2026 | 4.208 | 4.624 | 4.16 | 4.482 | 36913.00 |
| Aug 17, 2026 | 4.16 | 4.88 | 3.999 | 4.107 | 120949.0 |
| Aug 14, 2026 | 4.156 | 4.248 | 4.08 | 4.185 | 5691.00 |
| Aug 13, 2026 | 4.328 | 4.546 | 4.24 | 4.248 | 3644.00 |
| Aug 12, 2026 | 4.455 | 4.653 | 4.24 | 4.48 | 14636.00 |
| Aug 11, 2026 | 4.561 | 4.60 | 4.401 | 4.455 | 3690.00 |
| Aug 10, 2026 | 4.784 | 4.80 | 4.644 | 4.745 | 1831.00 |
| Aug 07, 2026 | 4.592 | 4.815 | 4.583 | 4.815 | 2747.00 |
| Aug 06, 2026 | 4.556 | 4.80 | 4.48 | 4.792 | 1683.00 |
| Aug 05, 2026 | 4.514 | 4.64 | 4.481 | 4.64 | 3002.00 |
| Aug 04, 2026 | 4.56 | 4.604 | 4.482 | 4.603 | 5530.00 |
| Aug 03, 2026 | 4.906 | 4.906 | 4.602 | 4.68 | 9106.00 |
| Jul 31, 2026 | 4.834 | 4.968 | 4.324 | 4.968 | 17611.00 |
| Jul 30, 2026 | 4.327 | 4.792 | 4.24 | 4.792 | 13496.00 |
| Jul 29, 2026 | 4.249 | 4.48 | 4.08 | 4.478 | 10892.00 |
| Jul 28, 2026 | 4.232 | 4.954 | 3.936 | 4.272 | 404863.0 |
| Jul 27, 2026 | 4.021 | 4.376 | 4.021 | 4.216 | 7573.00 |
| Jul 24, 2026 | 4.40 | 4.40 | 4.08 | 4.103 | 2759.00 |
| Jul 23, 2026 | 3.84 | 4.467 | 3.788 | 4.424 | 26244.00 |
| Jul 22, 2026 | 4.151 | 4.152 | 3.655 | 4.039 | 40957.00 |
| Jul 21, 2026 | 3.968 | 4.156 | 3.968 | 4.152 | 9744.00 |
| Jul 20, 2026 | 4.236 | 4.40 | 3.72 | 4.117 | 22621.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioLineRx Ltd. | 2.80 |
| XTL Biopharmaceuticals Ltd. | 2.53 |
| Kamada Ltd. | 8.42 |
| Can-Fite BioPharma Ltd. | 3.28 |
| Revium Recovery, Inc. | 1.43 |
Price Related Metrics
| Price to Book Value | 0.2377 |
| Earnings Yield | -398.1% |
| Market Cap | 3.316M |